BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong
· Delayed Price · Currency is HKD 3.820
+0.040 (1.06%)
Apr 29, 2026, 4:08 PM HKT
HKG:6681 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 220.05 | 122.31 | 67.2 | 11.29 | 2.3 |
| Revenue Growth (YoY) | 79.91% | 82.01% | 495.16% | 391.13% | - |
| Cost of Revenue | 130.6 | 68.3 | 35.14 | 7.99 | 1 |
| Gross Profit | 89.45 | 54.01 | 32.06 | 3.3 | 1.3 |
| Selling, General & Admin | 175.58 | 107.94 | 87.27 | 39.69 | 37.6 |
| Research & Development | 165.9 | 119.42 | 90.73 | 67.63 | 32.76 |
| Operating Expenses | 380.41 | 238.85 | 178.85 | 107.37 | 70.37 |
| Operating Income | -290.95 | -184.83 | -146.78 | -104.07 | -69.06 |
| Interest Expense | -23.99 | -22.03 | -20.22 | -19.22 | -6.39 |
| Interest & Investment Income | 13.65 | 0.63 | 2.08 | 3.9 | 1.33 |
| Currency Exchange Gain (Loss) | -8.83 | -0.33 | -0.07 | - | - |
| Other Non Operating Income (Expenses) | -3.06 | -22.11 | -25.77 | -0.29 | 0.05 |
| EBT Excluding Unusual Items | -313.18 | -228.67 | -190.76 | -119.68 | -74.08 |
| Merger & Restructuring Charges | - | - | -5.53 | - | - |
| Gain (Loss) on Sale of Investments | 1.12 | 30.12 | -162.54 | -382.65 | -623.76 |
| Gain (Loss) on Sale of Assets | -0.06 | 0 | -0.06 | -0.13 | 0.01 |
| Other Unusual Items | -4.14 | -0.01 | -0.22 | - | - |
| Pretax Income | -316.26 | -198.56 | -359.12 | -502.46 | -697.84 |
| Income Tax Expense | 0.1 | 0.05 | - | - | - |
| Earnings From Continuing Operations | -316.36 | -198.61 | -359.12 | -502.46 | -697.84 |
| Minority Interest in Earnings | 1.5 | 0.33 | 0.03 | 0.01 | 0 |
| Net Income | -314.86 | -198.28 | -359.08 | -502.45 | -697.84 |
| Net Income to Common | -314.86 | -198.28 | -359.08 | -502.45 | -697.84 |
| Shares Outstanding (Basic) | 1,176 | 904 | 584 | 281 | 150 |
| Shares Outstanding (Diluted) | 1,176 | 1,000 | 584 | 281 | 150 |
| Shares Change (YoY) | 17.58% | 71.29% | 108.01% | 86.78% | - |
| EPS (Basic) | -0.27 | -0.22 | -0.62 | -1.79 | -4.64 |
| EPS (Diluted) | -0.27 | -0.23 | -0.62 | -1.79 | -4.64 |
| Free Cash Flow | - | -163.37 | -152.84 | -117.08 | -60.01 |
| Free Cash Flow Per Share | - | -0.16 | -0.26 | -0.42 | -0.40 |
| Gross Margin | 40.65% | 44.16% | 47.71% | 29.20% | 56.72% |
| Operating Margin | -132.22% | -151.12% | -218.43% | -921.71% | -3004.09% |
| Profit Margin | -143.09% | -162.11% | -534.35% | -4450.02% | -30353.94% |
| Free Cash Flow Margin | - | -133.57% | -227.44% | -1036.94% | -2610.05% |
| EBITDA | -273.41 | -167.29 | -132.78 | -98.34 | -68.45 |
| EBITDA Margin | -124.25% | -136.77% | -197.59% | - | - |
| D&A For EBITDA | 17.55 | 17.55 | 14.01 | 5.73 | 0.61 |
| EBIT | -290.95 | -184.83 | -146.78 | -104.07 | -69.06 |
| EBIT Margin | -132.22% | -151.12% | -218.43% | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.